The new study used CNS Vital Signs test to evaluate the effects of Neumentix supplementation on cognitive performance compared to placebo.
Long-term supplementation with botanical ingredient shown to improve focus |
| [16-November-2017] |
| DES MOINES, Iowa, Nov. 16, 2017 /PRNewswire/ -- New human clinical trial data presented at the Society for Neuroscience on Wednesday, November 15 shows supplementation with patented Neumentix™ Phenolic Complex K110-42 supports sustained attention and focus in young, healthy individuals. The new study used CNS Vital Signs test to evaluate the effects of Neumentix supplementation on cognitive performance compared to placebo. The CNS test uses a series of computerized neurocognitive tests to assess brain function. Results showed significant improvement in sustained attention after 30 days which lasted through the 90-day study. These results indicate long-term supplementation with Neumentix can improve focus over time. Neumentix is a water-extracted natural dietary ingredient that was selectively bred to be high in polyphenols and targeted to support cognitive and physical performance. Previous research suggests key polyphenols in Neumentix support working memory function in the brain through at least four potential mechanisms of action. Polyphenols in Neumentix are suggested to support cognition by reducing oxidative stress, increasing acetylcholine, supporting the growth of new neurons and protecting existing cells. “Neumentix stands out in the growing brain health market with its sustained, non-stimulant benefits for concentration and focus with continued use,” said Kim Colletti, Global Cognition Product Manager at Kemin Human Nutrition and Health. “Young consumers are looking for long-term cognitive enhancement that will help them stay productive without crashing.” According to Research and Markets, the brain health supplement market is expected to reach $11.6 billion by 2024. About Kemin Industries Kemin (www.kemin.com) has been dedicated to using applied science to improve the quality of life for over half a century. As a global company touching 3.8 billion people every day with its products, Kemin is committed to improving the quality, safety and efficacy of food, feed and health-related products to feed a growing population and be a resource for others in need. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where over 500 specialty ingredients are made for humans and animals in the global feed and food industries, as well as the health, nutrition and beauty markets. The company provides product solutions and options to customers in more than 120 countries. A privately held, family-owned and operated company, Kemin has more than 2,500 global employees and operates in 90 countries including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, Singapore, South Africa and the United States. Media Contact:
View original content with multimedia:http://www.prnewswire.com/news-releases/neumentix-clinical-study-shows-sustained-attention-benefits-300557498.html SOURCE Kemin Industries |
